February 6, 2024

Q3 signs another agreement with a US-based Technology Consulting firm for Dashboarding, Analysis & ETL (Extraction, Transfer & Load – of Data) development

The Report generated in the Dashboards will be utilized by the Physicians & Doctors. The data to be utilized in the Dashboard is collected from different sources and is being used in the treatment and prevention of rare eye disease in the US. Development of the Dashboard in Power BI: will be representing the outcome of RPE65 gene (that helps to identify or detect this rare eye disease ) at physician & geography level. The technologies being utilized includes Power BI, Python & SSIS (SQL Integration Services).